title: PML in a patient without severe lymphocytopenia receiving dimethyl fumarate.
authors: University Medical Center Utrecht, Utrecht, the Netherlands d.nieuwkamp@umcutrecht.nl.
authors: Dennis J
authors: DJ
authors: Nieuwkamp
authors: Jean-Luc
authors: JL
authors: Murk
authors: Bob W
authors: BW
authors: van Oosten
authors: Charlotte H P
authors: CH
authors: Cremers
authors: Joep
authors: J
authors: Killestein
authors: Marco C
authors: MC
authors: Viveen
authors: Wim
authors: W
authors: Van Hecke
authors: Daphne W
authors: DW
authors: Frijlink
authors: Mike P
authors: MP
authors: Wattjes
mesh_terms: D000069462:Dimethyl Fumarate; D017809:Fatal Outcome; D005260:Female; D005650:Fumarates / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007958:Leukocyte Count; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*; D018655:Lymphocyte Count; D008231:Lymphopenia / Q000150:complications; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy
chemical_list: D005650:Fumarates; D007166:Immunosuppressive Agents; D000069462:Dimethyl Fumarate